Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» natural killer cell therapy
natural killer cell therapy
FDA sideswipes Neoleukin with clinical hold on lead immunotherapy candidate, sends shares plummeting
FDA sideswipes Neoleukin with clinical hold on lead immunotherapy candidate, sends shares plummeting
Endpoints
Neoleukin
NL-201
FDA
natural killer cell therapy
oncology
clinical trials
Flag link:
Sanofi inks $358M Kiadis takeover to acquire NK-cell platform
Sanofi inks $358M Kiadis takeover to acquire NK-cell platform
Fierce Biotech
Sanofi
Kiadis
M&A
Sarclisa
natural killer cell therapy
Flag link:
Natural killer biotech Artiva launches with $78M, industry veterans
Natural killer biotech Artiva launches with $78M, industry veterans
Fierce Biotech
immuno-oncology
natural killer cell therapy
Artiva
Flag link:
MD Anderson emerges with strong evidence for natural killer cell therapy, and Takeda looks like a winner
MD Anderson emerges with strong evidence for natural killer cell therapy, and Takeda looks like a winner
Endpoints
Takeda
MD Anderson
natural killer cell therapy
CAR-T
Flag link:
Sorrento Therapeutics and Celularity Aim to Adapt Natural Killer Cell Therapy to Treat Coronavirus
Sorrento Therapeutics and Celularity Aim to Adapt Natural Killer Cell Therapy to Treat Coronavirus
Motley Fool
Sorrento Therapeutics
Celularity
natural killer cell therapy
cell therapy
coronaviruses
Wuhan Coronavirus
Flag link:
